Interleukin-12 promotes enhanced resistance to Listeria monocytogenes infection of lead-exposed mice

Toxicology and Applied Pharmacology

Volumn 147, Issue 2, 1997, Pages 180-189

  Kishikawa, Hiroko ^a,b   Song, Renjie ^b   Lawrence, David A ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 6; LEAD; MEMBRANE ANTIGEN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; INFECTION RESISTANCE; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; SPLEEN; STRESS; T LYMPHOCYTE;

EID: 0031404703     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8308     Document Type: Article

References (48)

1. Abraham G. E., Buster J. E., Teller R. C. Radioimmunoassay of plasma cortisol. Anal. Lett. 5:1972;757-765.
2. Araneo B. A., Shelby J., Li G-Z., Ku W., Daynes R. A. Administration of dehydroepiandrosterone to burned mice preserves normal immunologic competence. Arch. Surg. 128:1993;318-325.
3. Bost K., Clements J. D. In vivo induction of interleukin-12 mRNA expression after oral immunization withSalmonella dublinEscherichia coli. Infect. Immun. 63:1995;1076-1083.
4. Chan S. H., Perussia B., Gupta J. W., Kobayashi M., Pospisil H. A., Young H. A., Wolf S. F., Clark S. C., Trinchieri G. Induction of interferon-γ production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:1991;869-879.
5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
6. Cohen H. J., Pieper C. F., Harris T., Rao K. M., Currie M. S. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J. Gerontol. A. Biol. Med. Sci. 52:1997;M201-M208.
7. Compton M. M., Cidlowski J. A. Thymocyte apoptosis. Trends Endocrinol. Metab. 3:1992;17-23.
8. Dalrymple S. A., Lucian L. A., Slattery R., McNeil T., Aud D. A., Fuchino S., Lee F., Murphy R. Interleukin-6-deficient mice are highly susceptible toListeria monocytogenes. Infect. Immun. 63:1995;2262-2268.
9. 2. EMBO J. 2:1983;1061-1065.
10. Ershler W. B., Sun W. H., Binkley N. The role of interleukin-6 in certain age-related diseases. Drugs Aging. 5:1994;358-365.
11. Ewers U., Stiller-Winkler R., Idel H. Serum immunoglobin, complement C3, ans salivary IgA levels in lead workers. Environ. Res. 29:1982;351-357.
12. Faith R. E., Luster M. L., Kimmel C. A. Effects of chronic developmental lead exposure on cell-mediated immune functions. Clin. Exp. Immunol. 35:1979;413-420.
13. Fukata J., Imura H., Nakao K. Cytokines as mediators in the regulation of the hypothalamic-pituitary-adrenocortical function. J. Endocrinol. Invest. 16:1993;141-155.
14. Gillessen S., Carvajal D., Podlaski F. J., Stremlo D. L., Familletti P. C., Gubler U., Presky D. H., Stern A. S., Gately M. K. Mouse interleukin-12 (IL-12) p40 homodimer: A potent IL-12 antagonist. Eur. J. Immunol. 25:1995;200-206.
15. Goyer R. A. Toxic effects of metals. Casarett and Doull's Toxicology: The Basic Science of Poisons. 1991;Pergamon Press, New York. p. 623-680.
16. Grant L. D., Davis J. M. Effects of low-level lead exposure on pediatric neurobehavioural development: current findings and future direction. Smith M. A., Grant L. D., Sors A. I. Lead Exposure and Child Development: An International Assessment. 1989;49-115 MTP Press, Lancaster.
17. Havell E. A., Sehgal P. B. Tumor necrosis factor-independent IL-6 production during murine Listeriosis. J. Immunol. 146:1991;756-761.
18. Heo Y., Parsons P. J., Lawrence D. A. Lead differentially modifies cytokine productionin vitroin vivo. Toxicol. Appl. Pharmacol. 138:1996;149-157.
19. Hiltbold E. M., Ziegler K. H. Mechanisms of processing and presentation of the antigens of Listeria monocytogenes. Infect. Agents Dis. 2:1994;314-323.
20. Hogquist K. A., Nett M. A., Sheehan K. C. F., Pendleton K. D., Schreiber R. D., Chaplin D. D. Generation of monoclonal antibodies to murine IL-1β and demonstration of IL-1in vivo. J. Immunol. 146:1991;1534-1540.
21. Ingle D. J. Effects of two steroid compounds on weight of thymus of adrenalectomized rats. Proc. Soc. Exp. Biol. Med. 44:1940;174-175.
22. Kawasaki E. S., Wang A. M. Detection of gene expression in PCR technology: principles and applications of DNA amplification. 1989;Stockton Press, New York.
23. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinernagel R., Bluethmann H., Kohler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 368:1994;339-342.
24. Kowolenko M., Tracy L., Lawrence D. A. Early effects of lead on bone marrow cell responsiveness in mice challenged with Listeria monocytogenes. Fundam. Appl. Toxicol. 17:1991;75-82.
25. Lawrence D. A. In vivoin vitro. Infect. Immun. 31:1981;136-143.
26. Lawrence D. A. Immunotoxicology of heavy metals. Dean J., Luster M., Munson A. E., Amos H. Immunotoxicology and Immunopharmacology. 1985;341-353 Raven Press, New York.
27. Lazar G., Lazar G. Jr., Husztik E., Duda E., Agarwal M. K. The influence of antiglucocorticoids on stress and shock. Ann. N.Y. Acad. Sci. 761:1995;276-295.
28. Ling P., Gately M. K., Gubler U., Stern A. S., Lin P., Hollfelder K., Su C., Pan Y. E., Hakimi J. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154:1995;116-127.
29. Lyson K., McCann S. M. Induction of adrenocorticotropic hormone release by interleukin-6in vivoin vitro. Ann. N.Y. Acad. Sci. 650:1992;182-185.
30. Mastorakos G., Chrousos G. P., Weber J. S. Recombinant interleukin-6 activates hypothalamic-pituitary-adrenal axis in humans. J. Clin. Endocrinol. Metab. 77:1993;1690-1694.
31. Mattner F., Fischer S., Guckes S., Jin S., Kaulen H., Schmitt E., Rude E., Germann T. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur. J. Immunol. 23:1993;2202-2208.
32. +. Toxicol. Appl. Pharmacol. 111:1991;13-23.
33. Montano M. M., Wang M., Even M. D., Vom saal F. S. Serum corticosterone in fetal mice: Sex differences, circadian changes, and effect of maternal stress. Physiol. Behav. 50:1991;323-329.
34. O'Garra A., Hosken N., Macatonia S., Wenner C. A., Murphy K. The role of macrophage- and dendritic cell-derived IL-12 in Th1 phenotype development. Res. Immunol. 146:1995;466-472.
35. Orange J. S., Salazar-Mather T. P., Opal S. M., Spence R. L., Miller A. H., McEwen B. S., Biron C. A. Mechanism of interleukin-12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:1995;901-914.
36. Orange J. S., Wolf S. F., Biron C. A. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152:1994;1253-1264.
37. Rabinowitz M. B., Alfred E. N., Bellinger D. C., Leviton A., Needleman H. L. Lead and childhood propensity to infections and allergic disorders: Is there an association? Bull. Environ. Contam. Toxicol. 44:1990;657-660.
38. Rosen J. F. Effects of low levels of lead exposure. Science. 256:1992;294.
39. Snick J. V., Cayphas S., Szikora J-P., Renauld J-C., Roost E. V., Boon T., Simpson R. J. cDNA cloning of murine interleukin-HP1: Homology with human interleukin 6. Eur. J. Immunol. 18:1988;193-197.
40. Stevenson M. M., Tam M. F., Wolf S. F., Sher A. IL-12-induced plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155:1995;2545-2556.
41. Taylor A. P., Murray H. W. Intracellular antimicrobial activity in the absence of interferon-γ: Effect of interleukin-12 in experimental visceral leishmaniasis in interferon-g gene-disrupted mice. J. Exp. Med. 185:1997;1231-1239.
42. Terao A., Oikawa M., Saito M. Tissue-specific increase in norepinephrine turnover by central interleukin-1, but not by interleukin-6, in rats. Am. J. Physiol. 266:1994;R400-R404.
43. Tian L., Lawrence D. A. Lead inhibits nitric oxide productionin vitro. Toxicol. Appl. Pharmacol. 132:1994;156-163.
44. Trinchieri G. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cell type 1 and cytotoxic lymphocytes. Blood. 84:1994;4008-4027.
45. Trinchieri G. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:1995;251-276.
46. Trinchieri G., Scott P. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions. Res. Immunol. 146:1995;423-431.
47. Tripp C. S., Unanue E. R. Macrophage production of IL-12 is a critical link between the innate and specific immune responses toListeria. Res. Immunol. 146:1995;515-519.
48. Yoshida A., Koide Y., Uchijima M., Yoshida T. O. Dissection of strain difference in acquired protective immunity againstMycobacterium bovis Calmette-Guerin Bacillus. J. Immunol. 155:1995;2057-2066.